Dok-1 and Dok-2 deficiency induces osteopenia via activation of osteoclasts

Journal of Cellular Physiology

Volumn 226, Issue 12, 2011, Pages 3087-3093

  Kawamata, Aya ^a   Inoue, Akane ^b   Miyajima, Daisuke ^a   Hemmi, Hiroaki ^a   Mashima, Ryuichi ^b   Hayata, Tadayoshi ^a   Ezura, Yoichi ^a   Amagasa, Teruo ^a   Yamanashi, Yuji ^b   Noda, Masaki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; COLONY STIMULATING FACTOR 1; DEOXYPYRIDINOLINE; PROTEIN DOK 1; PROTEIN DOK 2; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MASS; BONE MINERALIZATION; CELL ACTIVATION; CONTROLLED STUDY; CORTICAL BONE; FEMALE; LONG BONE; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; OSTEOPENIA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; TRABECULAR BONE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACIDS; ANIMALS; BIOLOGICAL MARKERS; BONE DISEASES, METABOLIC; BONE RESORPTION; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; DOWN-REGULATION; FEMUR; GENOTYPE; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOCLASTS; OSTEOGENESIS; PHENOTYPE; PHOSPHOPROTEINS; RNA-BINDING PROTEINS; STEM CELLS; TIBIA; X-RAY MICROTOMOGRAPHY;

EID: 80053154253     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22909     Document Type: Article

References (35)

1. Andersen T, Sondergaard T, Skorzynska K, Dagnaes-Hansen F, Plesner T, Hauge E, Plesner T, Delaisse J. 2008. A physical mechanism for coupling bone resorption and formation in adult human bone. Am J Pathol 174: 239-247.
2. Arai F, Miyamoto T, Ohneda O, Inada T, Sudo T, Brasel K, Miyata T, Anderson D, Suda T. 1999. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med 190: 1741-1754.
3. Beeson D, Higuchi O, Palace J, Cossins J, Spearman H, Maxwell S, Newsom-Davis J, Burke G, Fawcett P, Motomura M, Müller J, Lochmüller H, Slater C, Vincent A, Yamanashi Y. 2006. Dok-7 mutations underlie a neuromuscular junction synaptopathy. Science 313: 1975-1978.
4. Carpino N, Wisniewski D, Strife A, Marshak D, Kobayashi R, Stillman B, Clarkson B. 1997. p62(dok): A constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 88: 197-204.
5. Chapurlat R, Arlot M, Burt-Pichat B, Chavassieux P, Roux J, Portero-Muzy N, Delmas P. 2007. Microcrack frequency and bone remodeling in postmenopausal osteoporotic women on long-term bisphosphonates: A bone biopsy study. J Bone Miner Res 22: 1502-1509.
6. Cong F, Yuan B, Goff. S. 1999. Characterization of a novel member of the DOK family that binds and modulates Abl signaling. Mol Cell Biol 19: 8314-8325.
7. Crowder R, Enomoto H, Yang M, Johnson EJ, Milbrandt J. 2004. Dok-6, a novel p62 Dok family member, promotes Ret-mediated neurite outgrowth. J Biol Chem 279: 42072-42081.
8. Curtis J, Westfall A, Cheng H, Delzell E, Saag K. 2008. Risk of hip fracture after bisphosphonate discontinuation: Implications for a drug holiday. Osteoporos Int 19: 1613-1620.
9. Di Cristofano A, Carpino N, Dunant N, Friedland G, Kobayashi R, Strife A, Wisniewski D, Clarkson B, Pandolfi P, Resh M. 1998. Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins. J Biol Chem 273: 4827-4830.
10. Drake M, Clarke B, Khosla S. 2008. Bisphosphonates: Mechanism of action and role in clinical practice. Mayo Clin Proc 83: 1032-1045.
11. Ebeling P. 2008. Clinical practice. Osteoporosis in men. N Engl J Med 358: 1474-1482.
12. Gallagher J. 2008. Advances in bone biology and new treatments for bone loss. Maturitas 60: 65-69.
13. Hosooka T, Noguchi T, Kotani K, Nakamura T, Sakaue H, Inoue H, Ogawa W, Tobimatsu K, Takazawa K, Sakai M, Matsuki Y, Hiramatsu R, Yasuda T, Lazar M, Yamanashi Y, Kasuga M. 2008. Dok1 mediates high-fat diet-induced adipocyte hypertrophy and obesity through modulation of PPAR-gamma phosphorylation. Nat Med 14: 188-193.
14. Ishijima M, Rittling S, Yamashita T, Tsuji K, Kurosawa H, Nifuji A, Denhardt D, Noda M. 2001. Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin. J Exp Med 193: 399-404.
15. Jones N, Dumont DJ. 2000. Tek/Tie2 signaling: new and old partners. Cancer Metastasis Rev. 19: 13-17.
16. Kawamata A, Izu Y, Yokoyama H, Amagasa T, Wagner E, Nakashima K, Ezura Y, Hayata T, Noda M. 2008. JunD suppresses bone formation and contributes to low bone mass induced by estrogen depletion. J Cell Biochem 103: 1037-1045.
17. Lemay S, Davidson D, Latour S, Veillette A. 2000. Dok-3, a novel adapter molecule involved in the negative regulation of immunoreceptor signaling. Mol Cell Biol 20: 2743-2754.
18. Mashima R, Hishida Y, Tezuka T, Yamanashi Y. 2009. The roles of Dok family adapters in immunoreceptor signaling. Immunol Rev. 232: 273-285.
19. Mizoguchi F, Mizuno A, Hayata T, Nakashima K, Heller S, Ushida T, Sokabe M, Miyasaka N, Suzuki M, Ezura Y, Noda M. 2008. Transient receptor potential vanilloid 4 deficiency suppresses unloading-induced bone loss. J Cell Physiol 216: 47-53.
20. Morinobu M, Nakamoto T, Hino K, Tsuji K, Shen Z, Nakashima K, Nifuji A, Yamamoto H, Hirai H, Noda M. 2005. The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein-induced bone formation. J Exp Med 201: 961-970.
21. Nelms K, Snow AL, Hu-Li J, Paul WE. 1998. FRIP, a hematopoietic cell-specific rasGAP-interacting protein phosphorylated in response to cytokine stimulation. Immunity. 9: 13-24.
22. Niki M, Di Cristofano A, Zhao M, Honda H, Hirai H, Van Aelst L, Cordon-Cardo C, Pandolfi PP. 2004. Role of Dok-1 and Dok-2 in leukemia suppression. J Exp Med. 200: 1689-1695.
23. Noguchi T, Matozaki T, Inagaki K, Tsuda M, Fukunaga K, Kitamura Y, Kitamura T, Shii K, Yamanashi Y, Kasuga M. 1999. Tyrosine phosphorylation of p62(Dok) induced by cell adhesion and insulin: Possible role in cell migration. EMBO J 18: 1748-1760.
24. Okada K, Inoue A, Okada M, Murata Y, Kakuta S, Jigami T, Kubo S, Shiraishi H, Eguchi K, Motomura M, Akiyama T, Iwakura Y, Higuchi O, Yamanashi Y. 2006. The muscle protein Dok-7 is essential for neuromuscular synaptogenesis. Science 312: 1802-1805.
25. Ono N, Nakashima K, Schipani E, Hayata T, Ezura Y, Soma K, Kronenberg H, Noda M. 2007. Constitutively active parathyroid hormone receptor signaling in cells in osteoblastic lineage suppresses mechanical unloading-induced bone resorption. J Biol Chem 282: 25509-25516.
26. Rosen C. 2005. Clinical practice. Postmenopausal osteoporosis. N Engl J Med 353: 595-603.
27. Sebba A. 2008. Osteoporosis: How long should we treat? Curr Opin Endocrinol Diabetes Obes 15: 502-507.
28. Seeman E, Delmas P. 2006. Bone quality-The material and structural basis of bone strength and fragility. N Engl J Med 354: 2250-2261.
29. Shinohara H, Inoue A, Toyama-Sorimachi N, Nagai Y, Yasuda T, Suzuki H, Horai R, Iwakura Y, Yamamoto T, Karasuyama H, Miyake K, Yamanashi Y. 2005. Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling. J Exp Med 201: 333-339.
30. Sims N, Gooi J. 2008. Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption. Semin Cell Dev Biol 19: 444-451.
31. Usui M, Yoshida Y, Tsuji K, Oikawa K, Miyazono K, Ishikawa I, Yamamoto T, Nifuji A, Noda M. 2004. Tob deficiency superenhances osteoblastic activity after ovariectomy to block estrogen deficiency-induced osteoporosis. Proc Natl Acad Sci USA 101: 6653-6658.
32. Yamanashi Y, Baltimore D. 1997. Identification of the Abl- and rasGAP-associated 62kDa protein as a docking protein, Dok. Cell 88: 205-211.
33. Yamanashi Y, Tamura T, Kanamori T, Yamane H, Nariuchi H, Yamamoto T, Baltimore D. 2000. Role of the rasGAP-associated docking protein p62(dok) in negative regulation of B cell receptor-mediated signaling. Genes Dev 14: 11-16.
34. Yasuda T, Shirakata M, Iwama A, Ishii A, Ebihara Y, Osawa M, Honda K, Shinohara H, Sudo K, Tsuji K, Nakauchi H, Iwakura Y, Hirai H, Oda H, Yamamoto T, Yamanashi Y. 2004. Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia. J Exp Med 200: 1681-1687.
35. Yoshitake H, Rittling S, Denhardt D, Noda M. 1999. Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci USA 96: 8156-8160.